Skip to main content

Data Snapshot  

UW Medicine Hospitals:  

COVID-19 Positive Inpatients Chart May 26 20201

King County: The county reported 67 new positive cases and 0 new deaths on May 30.  

Washington: The state reported 401,526 cases and 5,765 deaths as of May 28.  

United States: The CDC reports 33,079,543 cases and 591,265 deaths as of May 30. 

Global: WHO reports 170,426,245 confirmed COVID-19 cases and 3,548,628 deaths as of June 1. 

Numbers update frequently, please follow links for most up-to-date numbers.  

UW Medicine COVID-19 Vaccine Distribution Update 

Total Vaccine Doses Administered: 320,125 

  • Total first dose: 163,857 
  • Total second dose: 156,258 

As of May 28, 2021. 

UW Medicine in the News 

KIRO 7: CDC to investigate WA myocarditis cases and possible link to COVID vaccine
Featuring: Shireesha Dhanireddy, Allergy & Infectious Diseases
“The Washington State Department of Health confirmed the number of myocarditis cases is not above the baseline the state sees each year, often triggered by a virus. The CDC, the Washington Chapter of the American Academy of Pediatrics and local health leaders said vaccinating your children is still the safest decision, as the impact of COVID-19 would be worse. ‘These reports of potential association that have not been confirmed should not be a reason to not get their children vaccinated,’ said Dr. Shireesha Dhanireddy, UW Medicine. The CDC is sending out a pediatric cardiologist and an adult cardiologist to help examine medical records and talk to patients.” 

The Spokesman-Review: Why health experts say you need a vaccine even if you had COVID-19
Featuring: Vin Gupta, IHME; John Lynch, Allergy & Infectious Diseases
“While some who have had COVID-19 might not have an interest in getting vaccinated, a growing body of evidence and cautionary tales from other countries indicate that natural immunity won’t be the answer to beating the pandemic. The most vulnerable people are those with no previous infection or vaccine, but new studies on vaccines and variants show that people who have had the virus but no vaccine are at more risk than those who are fully vaccinated. ‘The notion that you’ve had the virus before and you’re protected: we’re seeing time and again now that that’s untrue,’ said Dr. Vin Gupta, a physician and professor at the Institute for Health Metrics and Evaluation at the University of Washington. ‘We don’t have robust protection because of prior infection particularly because of transmission of these variants.’ The variant that originated in the United Kingdom, the B.1.1.7 variant, is the most common circulating in Washington state, and it has thus far been associated with more transmission and in some cases, more severe disease.”

COVID-19 Literature Report  

COVID-19 Literature Situation Reportis a daily (M-F) newsletter put together by the Alliance for Pandemic Preparedness that provides a succinct summary of the latest scientific literature related to the COVID-19 pandemic.

Key Takeaways: COVID-19 Literature Situation Report May 27, 2021 

  • Breakthrough SARS-CoV-2 infections at least 14 days following the first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines were 3-fold more common among those with frailty among adults aged ≥60 years, based on findings from a study that matched infected and non-infected vaccinated individuals in the UK. Vaccinated individuals who developed infection reported fewer symptoms and had 64% lower risk of hospitalization than matched non-vaccinated individuals. More. 
  • Two inactivated SARS-CoV-2 vaccines had efficacy >70% in preventing symptomatic COVID-19 14 days after the second dose in an interim analysis of a phase 3 trial among adults aged ≥18 years without known prior infection in the United Arab Emirates and Bahrain (n=38,206). Adverse reactions 7 days after each dose occurred in 42%-47% of participants, while serious adverse events occurred in ≤0.6% in all 3 groups. More. 
  • A randomized trial of the Pfizer-BioNTech vaccine (BNT162b2) among adolescents ages 12-15 reported vaccine efficacy of 100% (95% CI 75-100%) against COVID-19 for the 2-dose vaccine series. There were no vaccine-related serious adverse events and few overall adverse events. More.

COVID-19 Literature Surveillance Team, is an affiliated group of medical students, PhDs and physicians keeping up with the latest research on SARS-CoV-2 / COVID-19 by finding the newest articles, reading them, grading their level of evidence and bringing you the bottom line. 

Read the latest report: May 28 | Weekly COVID-19 LST Report. 

Tweet of the Week